Payment & Shipping Terms:
|Application||For lab research|
|Storage||Keep in cool and dry place|
|Package||aluminium alloy bag or according to requirement|
|Type of shipping||EMS, TNT, FEDEX, DHL, UPS|
|Payment terms||T/T or Western Union or Money Gram or Bitcoin|
|Delivery time||Within 1-3 days|
Edoxaban (DU-176b, trade names Savaysa, Lixiana) is an oral anticoagulant drug which acts as a direct factor Xa inhibitor. It was developed by Daiichi Sankyo and approved in July 2011 in Japan for prevention of venous thromboembolisms (VTE) following lower-limb orthopedic surgery. It was also approved by the FDA in January 2015 for the prevention of stroke and non–central-nervous-system systemic embolism.